143 Startups
  • Sector
  • Participated in
  • Year of participation

SimpleXable

  • 2022
  • Enabling Technology
  • Venture Challenge
Simplexable provides three-dimensional human scar models that are suitable for high content screening of compounds, targeting key events of hypertrophic scar formation.

Sirius Medical

  • 2015
  • Medical Device
  • Venture Challenge
The next generation of accurate and hassle-free tumor localization for breast cancer.

SLAM Orthopedic

  • 2020
  • Medical Device
  • Venture Challenge
SLAM Ortho has developed an automated, accurate and fast bore depth measurement system for use in orthopaedic trauma procedures for fractures in extremities

Spatium Medical

  • 2023
  • Medical Device
  • Venture Challenge
Spatium Medical introduces the world’s first medical insufflator that ensures stable workspace at lowest insufflation and ventilation pressure with three patented technologies addressing three unmet needs.

StemXBio

  • 2024
  • Enabling Technology
  • Venture Challenge
StemX Bio's revolutionary human in vitro 3D pancreatic model will completely transform the area of diabetes drug discovery. This innovative approach directly addresses the critical unmet need within the diabetes research community for more accurate and physiologically relevant in vitro models.

STENTiT

  • 2016
  • Medical Device
  • Venture Challenge
To become the new standard in vascular treatment. By bringing regenerative capacity for the first time to a stent, a wide range of clinical applications will benefit from our innovative approach.

T-Cell Factory

  • 2013
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
T Cell Factory (TCF) will identify and develop therapeutic T cell receptor (TCR) genes for the growing market of cancer therapies.

TargED Biopharmaceuticals

  • 2018
  • Therapeutics
  • Venture Challenge
We at TargED have developed MICROLYSE, an innovative fusion-protein that has an antibody domain that recognizes microthrombi and an enzymatic domain that breaks them down.

thromboDX

  • 2011
  • Diagnostics
  • Other
thromboDx BV is a molecular diagnostics company that develops and commercialises blood-based diagnostics through its proprietary platelet-powered technology platform

THRONCAT Analytics

  • 2024
  • Enabling Technology
  • Venture Challenge
THRONCAT Analytics offers a service in optimizing mRNA sequences for safety by detecting, identifying, and quantifying protein by-products of mRNA therapeutics.